A recent study proposed that maintaining low-dose, low-frequency psoralen—UV-A (PUVA) photochemotherapy could extend disease-free remission in individuals diagnosed with early-stage mycosis fungoides.

Citation: Vieyra-Garcia P, Fink-Puches R, Porkert S, et al. Evaluation of low-dose, low-frequency oral psoralen–UV-A treatment with or without maintenance on early-stage mycosis fungoides: A randomized clinical trial [Published online March 20, 2019]. JAMA Dermatol.